You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
We do not review or control the content on non-Medtronic sites, and we are not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site are not approved in your region or country.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
This information is designed to provide you with helpful educational information but is for information purposes only, is not medical advice, and should not be used as an alternative to speaking with your doctor. No representation is made that the information provided is current, complete, or accurate. Medtronic does not assume any responsibility for persons relying on the information provided. Be sure to discuss questions specific to your health and treatments with a healthcare professional. For more information please speak to your healthcare professional.
This information is designed to provide you with helpful educational information but is for information purposes only, is not medical advice, and should not be used as an alternative to speaking with your doctor. No representation is made that the information provided is current, complete, or accurate. Medtronic does not assume any responsibility for persons relying on the information provided. Be sure to discuss questions specific to your health and treatments with a healthcare professional. For more information please speak to your healthcare professional.
Hear from people who have successfully reduced their symptoms with help from Medtronic bladder control therapy.
READ PATIENT STORIESConnect with people who have experienced life-changing relief with Medtronic bladder control therapy.
REQUEST A CALLGet our e-newsletter for success stories and tips for managing and treating your condition.
SIGN UP NOWYou’re not alone. You’re taking the right steps to get the relief you seek, but it’s only natural to want to know every detail before getting started. You can find everything you need to know, right here.
A: This therapy targets the nerves that control your bladder to help it function normally again.
A: Medtronic bladder control therapy delivered by the InterStim™ system restores* bladder function by gently stimulating the sacral nerves.
A: It's thought that bladder control problems are caused by miscommunication between the brain and the sacral nerves, which control the bladder and muscles involved in urination.1
A: With this therapy, you may experience fewer trips to the bathroom, fewer accidents, and more confidence as you get back to the activities you enjoy.2
A: Implanting an InterStim system has risks similar to any surgical procedure, including swelling, bruising, bleeding, and infection. Talk with your doctor about ways to minimise these risks.
A: No. It can be effective, but it's not a cure. If the neurostimulator is turned off or removed, symptoms can return.
A: This therapy significantly reduced symptoms of OAB and non-obstructive urinary retention in people treated for 5 years.†,5,6 Each patients experience will be different.
A: Most people describe it as a slight pulling, tingling, or fluttering sensation in the pelvic area. It should not be painful. Stimulation settings can be adjusted, and sensations will vary from person to person.
A: You can try it before you decide, and it’s reversible if you change your mind later. †,2-4 And unlike injections, it doesn’t require self-catheterisation or repeated treatment visits.
A: Getting an MRI head scan may be possible under specific conditions.
A: Since its approval in 1997, InterStim therapy has been used to treat bladder control problems in hundreds of thousands of patients around the world.
Record your symptoms to help your doctor understand your condition.
191KB
The Bladder care pathway helps you understand all of the treatment options available for bladder control problems.
201KB
Fill in this questionnaire to identify your bladder control symptoms, and discuss the results with your doctor to learn more.
70KB
Discover more about your bladder control options with your healthcare professional with this Bladder Control Patient education brochure.
685KB
Bladder control problems affect millions of people. But relief is closer than you think.
SEE THE STEPSSpeak with a doctor in your community who can help you find the right treatment.
FIND A SPECIALISTWith the InterStim™ systems, restored bladder function is defined as a 50% or greater reduction in your troublesome bladder symptoms.
In addition to risks related to surgery, complications can include pain at the implant sites, new pain, infection, lead (thin wire) movement/migration, device problems, undesirable changes in urinary or bowel function, and uncomfortable stimulation (sometimes described as a jolting or shocking feeling).Talk with your doctor about ways to minimize these risks.
Under certain conditions.
Leng WW, Morrisroe SN. Sacral nerve stimulation for the overactive bladder. Urol Clin N Am. 2006;33:491–501.
Siegel S, Noblett K, Mangel J, et al. Results of a prospective, randomized, multicenter study evaluating sacral neuromodulation with InterStim® Therapy compared to standard medical therapy at 6-months in subjects with mild symptoms of overactive bladder. Neurourol Urodyn. 2015;34:224–230. DOI: 10.1002/nau.22544
Siegel S, Noblett K, Mangel J, et al. Five-year follow-up results of a prospective, multicenter study of patients with overactive bladder treated with sacral neuromodulation. The Journal of Urology 2018;Volume 199(1), 229–236.
Van Kerrebroeck P, et al. Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study. Journal of Urology. 2007;178:2029-2034.
Siegel S, Noblett K, Mangel J, et al. Results of a prospective, randomized, multicenter study evaluating sacral neuromodulation with InterStim® Therapy compared to standard medical therapy at 6-months in subjects with mild symptoms of overactive bladder. Neurourol Urodyn. 2015;34:224–230.